Keith Boundy to Double-Blind Method
This is a "connection" page, showing publications Keith Boundy has written about Double-Blind Method.
Connection Strength
0.049
-
Plotnik D, Sager JE, Aryal M, Fanget MC, Peter A, Schmid MA, Cebrik D, Mogalian E, Boundy K, Yeh WW, Griffin P, Reyes M. A phase 1 study in healthy volunteers to investigate the safety, tolerability, and pharmacokinetics of VIR-2482: a monoclonal antibody for the prevention of severe influenza A illness. Antimicrob Agents Chemother. 2024 04 03; 68(4):e0127323.
Score: 0.049